V. Lawlis
Fortune : 16 625 $ au 31/05/2026
Fortune : 16 625 $ au 31/05/2026
V.
Bryan Lawlis was the founder of Covance Biotechnology Services, Inc., founded in 1996, serving as Chairman from 1999 to 2001.
Dr. Lawlis was the founder of Itero Biopharmaceuticals LLC, founded in 2006, serving as President & Chief Executive Officer from 2006 to 2011.
Dr. Lawlis was the founder of Itero Biopharmaceuticals, Inc., founded in 2007, serving as President & Chief Executive Officer from 2007 to 2011.
Current jobs include Director at Tspan LLC since 2017 and Director at Comera Life Sciences, Inc. Former jobs include Chief Executive Officer & Director at Aradigm Corp.
from 2005 to 2006; President & Chief Executive Officer at Itero Holdings LLC from 2011 to 2017; Director at Humanigen, Inc. from 2013 to 2014; Independent Director at Sutro Biopharma, Inc. from 2003 to 2019; Director at GlycoFi, Inc.; Independent Director at Geron Corp.
from 2012 to 2026; Independent Director at Coherus Oncology, Inc. from 2014 to 2021; Independent Director at Absci Corp.; Director at Comera Life Sciences Holdings, Inc.; Independent Non-Executive Director at BioMarin Pharmaceutical, Inc. from 2014 to 2024; Independent Director at Spyre Therapeutics, Inc. from 2018 to 2022; Vice President-Process Sciences at Genentech, Inc. from 1981 to 1996; Senior Scientist at Genencor International, Inc. in 1996.
Education includes undergraduate studies at The University of Texas at Austin and a doctorate from Washington State University conferred in 1979.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/03/2026 | 13 300 ( 0 % ) | 16 625 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Tspan LLC
Tspan LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/07/2017 |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| GERON CORPORATION | Directeur/Membre du Conseil | 20/05/2026 |
| BIOMARIN PHARMACEUTICAL INC. | Directeur/Membre du Conseil | 21/05/2024 |
| SPYRE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 22/06/2022 |
| COHERUS ONCOLOGY, INC. | Directeur/Membre du Conseil | 22/05/2021 |
| SUTRO BIOPHARMA, INC. | Directeur/Membre du Conseil | 12/06/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 20 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Aradigm Corp.
Aradigm Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for the treatment and prevention of respiratory diseases | Health Technology |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Health Technology |
Humanigen, Inc.
Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Sutro Biopharma, Inc.
Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Itero Biopharmaceuticals, Inc.
Itero Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for novel therapeutic proteins and antibodies | Health Technology |
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Covance Biotechnology Services, Inc.
Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington State University
Washington State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlycoFi, Inc.
GlycoFi, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Coherus BioSciences, Inc.
Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
Itero Biopharmaceuticals LLC
Itero Biopharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Provides royalty payment services for licensing agreement | Commercial Services |
Absci Corp.
Absci Corp. BiotechnologyHealth Technology Engages in development of cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry | Health Technology |
Tspan LLC
Tspan LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Itero Holdings LLC
Itero Holdings LLC Financial ConglomeratesFinance Provides investment services | Finance |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Health Technology |
Comera Life Sciences Holdings, Inc.
Comera Life Sciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national